Lena Wange is Manager-Communications & Investor Relations at Orexo AB. View Lena Wange’s professional profile on Relationship Science, the database of decision makers.

Uppdrag i Bolaget: Styrelseledamot sedan 2019. Utbildning och erfarenhet: Nikolaj är VD och koncernchef för Orexo AB, ett offentligt svenskt

Orexo publishes Annual Report for 2020. 23 March 2021 · RDV · Regulatory. Orexo publishes prospectus and applies for admission to trading of corporate bonds. 16 March 2021 · Press Release · Regulatory Orexo publicerar årsredovisning för 2020. 23 mars 2021 · RDV · Regulatoriskt. Orexo offentliggör prospekt och ansöker om upptagande till handel av företagsobligationer 2021-04-08 2021-03-23.

Orexo AB Virdings Allé 32A Box 303 SE-751 05 Uppsala +46 (0)18 780 88 00 +46 (0)18 780 88 88 http://www.orexo.com IR@orexo.com För ytterligare information, kontakta: Beata Augenblick, Investor Relations Tel: 018-780 88 50 E-mail: beata.augenblick@orexo.com Om Orexo Orexo AB är ett växande specialistläkemedelsbolag som utvecklar förbättrade läkemedel baserade på egen drug delivery-teknologi. Orexo påkallar förtida inlösen av utestående obligationer och erhåller temporärt undantag från villkoren för utestående obligationer. Uppsala - 5 februari, 2021 - Orexo AB (publ), ("Orexo" eller "Bolaget") (STO:ORX) (OTCQX:ORXOY) har idag meddelat samtliga innehavare av Bolagets u Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden.. The US organization’s main mission is to commercialize the drug Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII) for treatment of opioid dependence on the American market. Orexo AB,556500-0600 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Orexo AB Investor Relations.

Nuvarande befattning och andra väsentliga uppdrag: BillerudKorsnäs AB, Orexo AB, Coor Service Management Holding AB och Ellos Group Holding AB. Arbetslivserfarenhet: CFO på OMX, Carnegie och Apoteket AB, VD på Apoteket AB och Finanschef på Investor AB. Innehav: 3 333 B-aktier Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022. OX124 To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com..

Investor Relations Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Orexo publishes Annual Report for 2020. 23 March 2021 · RDV · Regulatory.

Origo is a long-established and publically listed Nordic IT services and solutions provider with offices in Iceland and Sweden. Origo has been listed on the OMX

Nacka, Sweden, April 7, 2021: Atlas Copco has acquired IBVC Vacuum, S.L.U, known as Iberica Vacuum. The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal. Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020. Orexo AB Virdings Allé 32A Box 303 SE-751 05 Uppsala +46 (0)18 780 88 00 +46 (0)18 780 88 88 http://www.orexo.com IR@orexo.com För ytterligare information, kontakta: Beata Augenblick, Investor Relations Tel: 018-780 88 50 E-mail: beata.augenblick@orexo.com Om Orexo Orexo AB är ett växande specialistläkemedelsbolag som utvecklar förbättrade läkemedel baserade på egen drug delivery-teknologi. Orexo påkallar förtida inlösen av utestående obligationer och erhåller temporärt undantag från villkoren för utestående obligationer. Uppsala - 5 februari, 2021 - Orexo AB (publ), ("Orexo" eller "Bolaget") (STO:ORX) (OTCQX:ORXOY) har idag meddelat samtliga innehavare av Bolagets u Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden.. The US organization’s main mission is to commercialize the drug Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII) for treatment of opioid dependence on the American market.

This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons. This website uses cookies to ensure you get the best experience on our website. Read more. Investor relations.
Full programme for government

Uppsala - 23 mars, 2021 – Orexos årsredovisning för räkenskapsåret 2020 har publicerats. Årsredovisningen kan laddas ner på bolagets webbsida, www.orexo.se (investerare/rapporter, presentationer och audiocasts) och finns även tillgänglig som en PDF i.

ET). Participation from Market Makers and ECNs is strictly NAICS Code 44,4461. Ticker STO: ORX. Show More. Popular Searches: orexo ab. Orexo.
Lediga jobb kalmar

kunskapsskolan fruängen medarbetare
japan klimatfrågan
tulum all inclusive resorts
vilken gymnasielinje passar mig test
slovenien piran

Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company.

Med hänsyn till ökad risk för spridning av covid-19, vänligen ta del av nedan besökspolicy innan ni besöker vårt huvudkontor For investors This section of the website provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Information for investors is currently only available in Swedish. Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021.

Intyga faderskap växjö
ab formplast

ÅAC Microtec AB BTA · AAK · Aallon Group Oyj · Aarhus Karlshamn · ABB InCoax Networks · Incus Investor · indentive · Index Pharmaceuticals · InDex Orderingång · Öresund · Orexo · Orezone · OrganoClick · Orgo Tech

Betsson is listed on Nasdaq Stockholm Large Cap (BETS). Betsson AB's Q4 and full year report 2020 was published on 9 February 2021 at 7:30 CEST. On the same day, there was a presentation of the results via webcast by CEO Pontus Lindwall and CFO Martin Öhman. Investor Relations Here, we’ll publish news and financial reports to help you assess Catena Media as an investment.